Last modified: 25 Mar 2016 11:37
This course is aimed at the understanding of novel areas of drug discovery with the specific aim of understanding the roles immunology and peptide chemistry play in informing the development of antibody and small molecule peptide-based biologic therapies for diverse diseases.
| Study Type | Postgraduate | Level | 5 |
|---|---|---|---|
| Term | Second Term | Credit Points | 25 credits (12.5 ECTS credits) |
| Campus | None. | Sustained Study | No |
| Co-ordinators |
|
||
This course will focus on the new and developing area of large molecule therapeutics. The inherent toxicity problems of synthetic, small molecule drugs are newsworthy with safety concerns for patients and significant negative impact on drug company valuations. Biologics or large molecule drugs are typically derived from natural sources and early indications would suggest that they are safe, efficacious and profitable. This course will focus on the use of therapeutic antibodies and immunopeptides for the treatment of a wide variety of clinical conditions. Wherever possible the course will use real clinical examples to deliver its applied message effectively and clearly. The course will also include presentations from industry professionals.
Information on contact teaching time is available from the course guide.
Group presentation (20%), flyer (20%), 2 essays (30% each).
There are no assessments for this course.
We have detected that you are have compatibility mode enabled or are using an old version of Internet Explorer. You either need to switch off compatibility mode for this site or upgrade your browser.
